Crohn's disease (CD) and ulcerative colitis (UC) are chronic, relapsing, inflammatory
disorders of the digestive tract that characteristically develop in adolescence and early …

The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of
maldigestion and malabsorption among patients with obvious risk factors that permitted the …

BACKGROUND & AIMS: Proton pump inhibitors (PPIs) and nonsteroidal anti-inflammatory
drugs (NSAIDs) are among the most commonly used classes of drugs, with the former …

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal
disorders encountered in clinical practice. It is a heterogeneous disorder with a multifactorial …

ContextIrritable bowel syndrome (IBS), which affects 11% to 14% of the population, is a
puzzling condition with multiple models of pathophysiology including altered motility …

Background The symptoms and signs of small intestinal bacterial overgrowth (SIBO) are
often identical to a variety of diseases and can lead to diagnostic confusion. Aims To review …

Small intestinal bacterial overgrowth is common in intestinal failure. Its occurrence relates to
alterations in intestinal anatomy, motility, and gastric acid secretion. Its presence may …

Background A growing number of studies seem to suggest that small intestinal bacterial
overgrowth (SIBO) is a common clinical problem. Although various techniques are available …

Abstract Rifaximin (4-deoxy-4)-methylpyrido [1), 2)-1, 2] imidazo-[5, 4-c]-rifamycin SV) is a
synthetic antibiotic designed to modify the parent compound, rifamycin, in order to achieve …

Background & Aims: To better understand the role of small intestinal bacterial overgrowth
(SIBO) in rosacea, we aimed to assess the presence of SIBO in patients with rosacea and …